Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician.

Journal Article (Review)

Patients with prosthetic heart valves require chronic oral anticoagulation. In this clinical scenario, physicians must be mindful of the thromboembolic and bleeding risks related to chronic anticoagulant therapy. Currently, only vitamin K antagonists are approved for this indication. This paper reviews the main heart valve guidelines focusing on the use of oral anticoagulation in these patients.

Full Text

Published version (via Digital Object Identifier)

Duke Authors

Cited Authors

Leiria, TLL; Lopes, RD; Williams, JB; Katz, JN; Kalil, RAK; Alexander, JH

Published Date

May 2011

Published In

Journal of Thrombosis and Thrombolysis

Volume / Issue

31 / 4

Start / End Page

514 - 522

PubMed ID

21327503

Electronic International Standard Serial Number (EISSN)

1573-742X

International Standard Serial Number (ISSN)

0929-5305

Digital Object Identifier (DOI)

10.1007/s11239-011-0574-9

Scholars@Duke